Owl Creek Asset Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-300,200
Closed -$25.5K 233
2022
Q4
$25.5K Hold
300,200
﹤0.01% 163
2022
Q3
$68K Hold
300,200
﹤0.01% 171
2022
Q2
$68K Hold
300,200
﹤0.01% 213
2022
Q1
$231K Hold
300,200
0.01% 195
2021
Q4
$360K Hold
300,200
0.02% 219
2021
Q3
$303K Buy
+300,200
New +$315K 0.01% 221

Other funds holding GRNAW

Owl Creek Asset Management's GRNAW Position: Q1 2023 in Review

Owl Creek Asset Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q1 2023, closing a stake of 300,200 shares — an estimated $25.5K sold.

Owl Creek Asset Management first reported a position in GRNAW in Q3 2021 and held it in 6 quarters. The position peaked at $360K in Q4 2021. 20 funds tracked by Wall St. Rank hold GRNAW as of Q1 2023.

  • Owl Creek Asset Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q1 2023 after selling out during the quarter.
  • Owl Creek Asset Management sold 300,200 GreenLight Biosciences Holdings, PBC Warrant shares in Q1 2023, an estimated $25.5K.
  • Owl Creek Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 6 quarters.
  • Owl Creek Asset Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $360K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q1 2023.

Based on Owl Creek Asset Management's 13F filing for Q1 2023, filed 15 May 2023.